Your Article Summary
See Latest ArticlesOn the Horizon: New Expression Systems to Become Common Industry Platforms
BioPharm, 06/22/09
New, alternative expression systems in various stages of development are showing their viability in large-scale protein manufacture. So, the question is no longer if an alternative platform will emerge, but which of the more than 340 expressions systems and associated genetic engineering technologies available for licensing will become the next common industry platform. In any case, it's very likely that the industry will be seeing broader diversity in the expression systems used at the commercial level over the next five years.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1
Roche, 12/10/09
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09